Hormone-refractory prostate cancer+1
Not recruitingStudy of PF-06821497 with Enzalutamide for Men with Metastatic Castration-Resistant Prostate Cancer Previously Treated with Abiraterone Acetate
Study of PF-06821497 with Enzalutamide for Men with Metastatic Castration-Resistant Prostate Cancer Previously Treated with Abiraterone Acetate
- Disease:Hormone-refractory prostate cancerProstate cancer metastatic
- Substances:DexamethasoneDocetaxel+3
France- Participants:18–64 years · 65+ years
- Substances:Dexamethasone
- Sponsor:Pfizer Inc.










